Govorestat, First And Only Potential Treatment For Classic Galactosemia, Does Not Receive FDA Approval
Govorestat, First And Only Potential Treatment For Classic Galactosemia, Does Not Receive FDA Approval . (MENAFN - PR Newswire) 
  
  
 
 
   
  Galactosemia Foundation Urges FDA to Reconsider on Behalf of Rare Disease Community Facing Devastating Disease  
  ALBANY, N.Y., Nov. 27, 2024 /PRNewswire/ ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108933991/Govorestat-First-And-Only-Potential-Treatment-For-Classic-Galactosemia-Does-Not-Receive-FDA-Approval
2024-11-27
rss
(MENAFN - PR Newswire) 
  
  
 
 
   
  Galactosemia Foundation Urges FDA to Reconsider on Behalf of Rare Disease Community Facing Devastating Disease  
  ALBANY, N.Y., Nov. 27, 2024 /PRNewswire/ ...
Govorestat, First And Only Potential Treatment For Classic Galactosemia, Does Not Receive FDA Approval